The Pro-Survival Oct4/Stat1/Mcl-1 Axis Is Associated with Poor Prognosis in Lung Adenocarcinoma Patients

The Pro-Survival Oct4/Stat1/Mcl-1 Axis Is Associated with Poor Prognosis in Lung Adenocarcinoma Patients

The embryonic stem cell marker Oct4 is expressed in several human cancers and is positively correlated with a poor outcome in cancer patients. However, its physiological role in cancer progression remains poorly understood. Tumor cells block apoptosis to escape cell death so that they can proliferat...

Full description

Bibliographic Details
Main Authors:	Yu-Chu Su, Yi-Cheng Chen, Yau-Lin Tseng, Gia-Shing Shieh, Pensee Wu, Ai-Li Shiau, Chao-Liang Wu
Format:	Article
Language:	English
Published:	MDPI AG 2021-10-01
Series:	Cells
Subjects:	lung adenocarcinoma anti-apoptosis cell survival Oct4 Stat1 Mcl-1
Online Access:	https://www.mdpi.com/2073-4409/10/10/2642

Similar Items

Cryptotanshinone chemosensitivity potentiation by TW-37 in human oral cancer cell lines by targeting STAT3–Mcl-1 signaling
by: In-Hyoung Yang, et al.
Published: (2020-08-01)

Activation of Interferon Signaling in Chronic Lymphocytic Leukemia Cells Contributes to Apoptosis Resistance via a JAK-Src/STAT3/Mcl-1 Signaling Pathway
by: Brigitte Bauvois, et al.
Published: (2021-02-01)

Anti-Growth, Anti-Angiogenic, and Pro-Apoptotic Effects by CX-4945, an Inhibitor of Casein Kinase 2, on HuCCT-1 Human Cholangiocarcinoma Cells via Control of Caspase-9/3, DR-4, STAT-3/STAT-5, Mcl-1, eIF-2α, and HIF-1α
by: Saini Wang, et al.
Published: (2022-06-01)

Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer
by: Yin-Hsun Feng, et al.
Published: (2019-08-01)

Therapeutic effects of an innovative BS-HH-002 drug on pancreatic cancer cells via induction of complete MCL-1 degradation
by: A-min Wang, et al.
Published: (2022-01-01)

Noxa/Mcl-1 Balance Regulates Susceptibility of Cells to Camptothecin-Induced Apoptosis
by: Yide Mei, et al.
Published: (2007-10-01)

Targeting MCL-1 protein to treat cancer: opportunities and challenges
by: Shady I. Tantawy, et al.
Published: (2023-07-01)

Irradiation Suppresses IFNγ-Mediated PD-L1 and MCL1 Expression in EGFR-Positive Lung Cancer to Augment CD8<sup>+</sup> T Cells Cytotoxicity
by: Chun-I. Wang, et al.
Published: (2021-09-01)

OTUD1 Activates Caspase‐Independent and Caspase‐Dependent Apoptosis by Promoting AIF Nuclear Translocation and MCL1 Degradation
by: Qingyu Luo, et al.
Published: (2021-04-01)

Mcl-1 Protein and Viral Infections: A Narrative Review
by: Zbigniew Wyżewski, et al.
Published: (2024-01-01)

Inhibition of cyclin E1 sensitizes hepatocellular carcinoma cells to regorafenib by mcl-1 suppression
by: Jianliang Xu, et al.
Published: (2019-07-01)

Loss of a Single Mcl-1 Allele Inhibits MYC-Driven Lymphomagenesis by Sensitizing Pro-B Cells to Apoptosis
by: Stephanie Grabow, et al.
Published: (2016-03-01)

Targeting MCL-1 in cancer: current status and perspectives
by: Haolan Wang, et al.
Published: (2021-04-01)

Targeting Mcl-1 Degradation by Bergenin Inhibits Tumorigenesis of Colorectal Cancer Cells
by: Yu Gan, et al.
Published: (2023-02-01)

Effect of oxaliplatin on the survival rate of human Y79 cells after down-regulation of Mcl-1
by: Lu Zhou, et al.
Published: (2017-12-01)

Timed degradation of Mcl-1 controls mitotic cell death
by: Paul R. Clarke, et al.
Published: (2018-11-01)

The VTLISFG motif in the BH1 domain plays a significant role in regulating the degradation of Mcl-1
by: Kang Xiao, et al.
Published: (2014-01-01)

KRIBB11 Induces Apoptosis in A172 Glioblastoma Cells via MULE-Dependent Degradation of MCL-1
by: Kyunghyun Yoo, et al.
Published: (2021-07-01)

Downregulation of Mcl-1 by Panobinostat Potentiates Proton Beam Therapy in Hepatocellular Carcinoma Cells
by: Changhoon Choi, et al.
Published: (2021-03-01)

DYRK1A suppression restrains Mcl-1 expression and sensitizes NSCLC cells to Bcl-2 inhibitors
by: Yangling Li, et al.
Published: (2020-05-01)

Drug Repurposing: Deferasirox Inhibits the Anti-Apoptotic Activity of Mcl-1
by: Bourafai-Aziez A, et al.
Published: (2021-12-01)

Inhibition of BMI-1 Induces Apoptosis through Downregulation of DUB3-Mediated Mcl-1 Stabilization
by: Kaixin Wu, et al.
Published: (2021-09-01)

Development of an MCL-1-related prognostic signature and inhibitors screening for glioblastoma
by: Ao Zhang, et al.
Published: (2023-07-01)

Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells
by: Leyi Yao, et al.
Published: (2022-07-01)

BOK-MCL1 transmembrane interactions: a challenging target for cancer therapy
by: Mónica Sancho, et al.
Published: (2021-01-01)

A novel Mcl-1 inhibitor synergizes with venetoclax to induce apoptosis in cancer cells
by: Tianming Zhao, et al.
Published: (2023-01-01)

MCL-1 Inhibitor S63845 Distinctively Affects Intramedullary and Extramedullary Hematopoiesis
by: Hexiao Zhang, et al.
Published: (2023-03-01)

A Structure-Guided Designed Small Molecule Is an Anticancer Agent and Inhibits the Apoptosis-Related MCL-1 Protein
by: Ingrid V. Machado, et al.
Published: (2023-07-01)

Thymic Stromal Lymphopoietin Interferes with the Apoptosis of Human Skin Mast Cells by a Dual Strategy Involving STAT5/Mcl-1 and JNK/Bcl-x<sub>L</sub>
by: Tarek Hazzan, et al.
Published: (2019-08-01)

Honokiol Suppressed Pancreatic Cancer Progression via miR-101/Mcl-1 Axis
by: Wang Y, et al.
Published: (2020-07-01)

PBRM1 loss is associated with increased sensitivity to MCL1 and CDK9 inhibition in clear cell renal cancer
by: Norman Fultang, et al.
Published: (2024-02-01)

The deubiquitinating enzyme OTUD1 antagonizes BH3-mimetic inhibitor induced cell death through regulating the stability of the MCL1 protein
by: Lanqin Wu, et al.
Published: (2019-08-01)

Albendazole-Induced SIRT3 Upregulation Protects Human Leukemia K562 Cells from the Cytotoxicity of MCL1 Suppression
by: Liang-Jun Wang, et al.
Published: (2020-05-01)

Chlamydia trachomatis-containing vacuole serves as deubiquitination platform to stabilize Mcl-1 and to interfere with host defense
by: Annette Fischer, et al.
Published: (2017-03-01)

Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis
by: Goncharenko-Khaider Nadzeya, et al.
Published: (2012-11-01)

Selective Small Molecule Myeloid Cell Leukemia-1 (MCL-1) Inhibitors: Novel Agents in Cancer Therapy
by: Hoda Sobhy Ibrahim, et al.
Published: (2019-12-01)

Mcl-1 Ubiquitination: Unique Regulation of an Essential Survival Protein
by: Barbara Mojsa, et al.
Published: (2014-05-01)

Downregulation of CDC20 Increases Radiosensitivity through Mcl-1/p-Chk1-Mediated DNA Damage and Apoptosis in Tumor Cells
by: Yang Gao, et al.
Published: (2020-09-01)

Upregulation of Mcl-1S Causes Cell-Cycle Perturbations and DNA Damage Accumulation
by: Alena Y. Streletskaia, et al.
Published: (2020-09-01)

Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma
by: Omar S. Al-Odat, et al.
Published: (2021-07-01)